Cognitive alterations in patients recovered from COVID-19 treated in Cardiopulmonary Rehabilitation
Licencia CC 4.0 (BY-NC-ND) © 2023 Revista Médica del Instituto Mexicano del Seguro Social..
Background: COVID-19 is associated with multiple complications, in addition to those produced at the pulmonary level. Post-COVID-19 cognitive deficits have been detected in the cognitive domain of attention and executive functions, even 4 months after COVID-19.
Objective: to determine the frequency of cognitive alterations in patients recovered from COVID-19.
Material and methods: A cross-sectional, descriptive and analytical study was carried out. Records of patients in care after infection by SARS-CoV-2 were integrated, the Neuropsi test was applied. Descriptive statistics and association tests were used through the Chi square test, taking p < 0.05 as significant.
Results: Data from 44 files were integrated. The median age, I place them in the sixth decade of life. There was a predominance of men (63.6%). The most frequent comorbidities were systemic arterial hypertension (50%) and diabetes mellitus (40.9%). Most of the patients were managed only at home (61.4%) with a moderate-severe COVID-19 picture (68.2%). The most affected dimensions of the Neuropsi test were attention and concentration (47.7%, mild alteration) and short-term memory (77.3%, mild alteration).
Conclusions: Cognitive impairment in patients recovered from COVID-19 assessed through the Neuropsi test presented mild alterations in attention and concentration, as well as in short-term memory. These could affect functionality, quality of life and ability to perform work.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 61(2023), 6 vom: 06. Nov., Seite 796-801 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Alteraciones cognitivas en pacientes recuperados de COVID-19 atendidos en Rehabilitación Cardiopulmonar |
|---|
| Beteiligte Personen: |
Domínguez-Paredes, Ana Luisa [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.11.2023 Date Revised 14.12.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.5281/zenodo.10064351 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364865970 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364865970 | ||
| 003 | DE-627 | ||
| 005 | 20231227132046.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.5281/zenodo.10064351 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1226.xml |
| 035 | |a (DE-627)NLM364865970 | ||
| 035 | |a (NLM)37995338 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Domínguez-Paredes, Ana Luisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cognitive alterations in patients recovered from COVID-19 treated in Cardiopulmonary Rehabilitation |
| 246 | 3 | 3 | |a Alteraciones cognitivas en pacientes recuperados de COVID-19 atendidos en Rehabilitación Cardiopulmonar |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.11.2023 | ||
| 500 | |a Date Revised 14.12.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Licencia CC 4.0 (BY-NC-ND) © 2023 Revista Médica del Instituto Mexicano del Seguro Social. | ||
| 520 | |a Background: COVID-19 is associated with multiple complications, in addition to those produced at the pulmonary level. Post-COVID-19 cognitive deficits have been detected in the cognitive domain of attention and executive functions, even 4 months after COVID-19 | ||
| 520 | |a Objective: to determine the frequency of cognitive alterations in patients recovered from COVID-19 | ||
| 520 | |a Material and methods: A cross-sectional, descriptive and analytical study was carried out. Records of patients in care after infection by SARS-CoV-2 were integrated, the Neuropsi test was applied. Descriptive statistics and association tests were used through the Chi square test, taking p < 0.05 as significant | ||
| 520 | |a Results: Data from 44 files were integrated. The median age, I place them in the sixth decade of life. There was a predominance of men (63.6%). The most frequent comorbidities were systemic arterial hypertension (50%) and diabetes mellitus (40.9%). Most of the patients were managed only at home (61.4%) with a moderate-severe COVID-19 picture (68.2%). The most affected dimensions of the Neuropsi test were attention and concentration (47.7%, mild alteration) and short-term memory (77.3%, mild alteration) | ||
| 520 | |a Conclusions: Cognitive impairment in patients recovered from COVID-19 assessed through the Neuropsi test presented mild alterations in attention and concentration, as well as in short-term memory. These could affect functionality, quality of life and ability to perform work | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Cognitive Dysfunction | |
| 650 | 4 | |a Coronavirus Infections | |
| 650 | 4 | |a Disfunción Cognitiva | |
| 650 | 4 | |a Infecciones por Coronavirus | |
| 650 | 4 | |a Post-Acute COVID-19 Syndrome | |
| 650 | 4 | |a Síndrome Post Agudo de COVID-19 | |
| 700 | 1 | |a Varela-Tapia, Clara Lilia |e verfasserin |4 aut | |
| 700 | 1 | |a Dorado-Arias, Valeska |e verfasserin |4 aut | |
| 700 | 1 | |a Salazar-Núñez, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Barro, Daniel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 61(2023), 6 vom: 06. Nov., Seite 796-801 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2023 |g number:6 |g day:06 |g month:11 |g pages:796-801 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5281/zenodo.10064351 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2023 |e 6 |b 06 |c 11 |h 796-801 | ||